Oncologists communicating with patients about assisted dying.


Journal

Current opinion in supportive and palliative care
ISSN: 1751-4266
Titre abrégé: Curr Opin Support Palliat Care
Pays: United States
ID NLM: 101297402

Informations de publication

Date de publication:
03 2019
Historique:
pubmed: 5 1 2019
medline: 18 12 2019
entrez: 5 1 2019
Statut: ppublish

Résumé

Across all jurisdictions in which assisted dying is legally permissible, cancer is the primary reported underlying diagnosis. Therefore, oncologists are likely to be asked about assisted dying and should be equipped to respond to inquiries or requests for assisted dying. Because Medical Assistance in Dying was legalized in Canada in 2016, it is a relatively new end-of-life practice and has prompted the need to revisit the academic literature to inform communication with patients about assisted dying. We reviewed applicable literature published in the past 5 years, pertaining to assisted dying and communication. In total, 86 articles were identified, 21 were flagged as relevant to review in detail, and six were included in the review. Key themes included perceived barriers and benefits to communicating with patients on the topic, pragmatic approaches for facilitating the conversation with patients, and the issue of proactively discussing assisted dying by broaching it as an option with patients. These findings indicate that there is still discomfort around having conversations about assisted dying with patients but new tools and approaches are being developed to support the practice.

Identifiants

pubmed: 30608240
doi: 10.1097/SPC.0000000000000411
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

59-63

Auteurs

Debbie Selby (D)

Sunnybrook Health Sciences Centre.
Department of Family and Community Medicine.

Sally Bean (S)

Sunnybrook Health Sciences Centre.
Dalla Lana School of Public Health, University of Toronto, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH